NOUVEAUX PEPTIDES ET COMBINAISON DE PEPTIDES À UTILISER DANS L'IMMUNOTHÉRAPIE DU CANCER DU POUMON, Y COMPRIS LE CPNPC, LE CPPC ET D'AUTRES CANCERS

摘要

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.